These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia. Artiges A. Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772 [Abstract] [Full Text] [Related]
5. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use. Lensing HH, Behr-Gross ME, Daas A, Spieser JM. Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226 [Abstract] [Full Text] [Related]
7. Alternatives to animal testing: achievements and recent developments in the European Pharmacopoeia. Castle P. Dev Biol Stand; 1996; 86():21-9. PubMed ID: 8785951 [Abstract] [Full Text] [Related]
8. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed. Sesardic D, Winsnes R, Rigsby P, Tierney R, Gaines-Das R. Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430 [Abstract] [Full Text] [Related]
9. A 4R concept for the safety testing of immunobiologicals. Cussler K. Dev Biol Stand; 1999 Mar; 101():121-6. PubMed ID: 10566784 [Abstract] [Full Text] [Related]
10. The target animal safety test--is it still relevant? Advisory Group on Alternatives to Animal Testing in Immunobiologicals. Biologicals; 2002 Dec; 30(4):277-87. PubMed ID: 12474863 [Abstract] [Full Text] [Related]
13. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulins. Gross S, Janssen SW, de Vries B, Terao E, Daas A, Buchheit KH. Biologicals; 2010 Jul; 38(4):501-10. PubMed ID: 20399681 [Abstract] [Full Text] [Related]
14. Three Rs potential in the development and quality control of immunobiologicals. Halder M. ALTEX; 2001 Jul; 18 Suppl 1():13-47. PubMed ID: 11854853 [Abstract] [Full Text] [Related]
15. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines]. Cussler K, Borrmann E, Werner E. Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369 [Abstract] [Full Text] [Related]
17. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations. Terao E, Daas A, Rautmann G, Buchheit KH. Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487 [Abstract] [Full Text] [Related]
18. Calibration of replacement international standard and European Pharmacopoeia Biological Reference Preparation for Diphtheria Toxoid, Adsorbed. Sesardic D, Winsnes R, Rigsby P, Gaines-Das R. Biologicals; 2001 Jun; 29(2):107-22. PubMed ID: 11580215 [Abstract] [Full Text] [Related]
19. [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines]. Wanko R, Unkelbach U. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1221-1227. PubMed ID: 28921172 [Abstract] [Full Text] [Related]
20. Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests. Gommer AM. Dev Biol Stand; 1996 Nov; 86():217-24. PubMed ID: 8785952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]